// App-Quantinova.ai

TCT-313 : Incidence and Impact of Major Bleeding Events After PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial

Researchers

Presenter

  • Gennaro Giustino

Principal Investigators

  • Bjorn Redfors

  • Roxana Mehran

  • Shmuel Chen

  • Patrick Serruys

  • Joseph Sabik

  • John Puskas

  • David Kandzari

  • Marie-Claude Morice

  • Nicholas Lembo

  • William Brown

  • David Taggart

  • Zixuan Zhang

  • Ovidiu Dressler

  • Stuart Pocock

  • Ori Ben-Yehuda

  • Gregg Stone

Medical Centers

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York

  • Oxford University, Oxford, United Kingdom

  • The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, New York, NY

  • Columbia University Medical Center, New York, New York, USA

  • Cardiovascular Research Foundation, New York, New York, USA

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio

  • Piedmont Heart Institute CardioThoracic Surgeons, Atlanta, Georgia

  • Imperial College, London, United Kingdom

  • Piedmont Heart Institute, Atlanta, Georgia

  • Icahn School of Medicine at Mount Sinai, New York, New York, USA

  • Mount Sinai, New York, New York

  • CERC, Massy, France

Locations

  • United Kingdom

  • United States

  • Georgia

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Left main disease

  • Myocardial infarction

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final